Company record · updated August 5, 2026
Mobia Medical, Inc.: 6 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs April 17, 2026 to April 17, 2026.
6observations
1source filings
6verified rows
2026-04-17most recent as-of date
Source rails for this company: S-1 charter round (6).
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-04-17 | Series E-2 price per share | 2.5443 USD | — | VERIFIED | "Original Issue Price" defined for Series E-2 | 000162828026025811 |
| 2026-04-17 | Series E-1 price per share | 2.5443 USD | — | VERIFIED | "Original Issue Price" defined for Series E-1 | 000162828026025811 |
| 2026-04-17 | Series D price per share | 2.0354 USD | — | VERIFIED | "Original Issue Price" defined for Series D | 000162828026025811 |
| 2026-04-17 | Series C price per share | 4.207 USD | — | VERIFIED | "Original Issue Price" defined for Series C | 000162828026025811 |
| 2026-04-17 | Series B price per share | 4.207 USD | — | VERIFIED | "Original Issue Price" defined for Series B | 000162828026025811 |
| 2026-04-17 | Series A price per share | 3.7374 USD | — | VERIFIED | "Original Issue Price" defined for Series A | 000162828026025811 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.